Can the peptide receptor radionuclide therapy [177Lu]Lu-DOTA-TATE provide a net benefit for NET patients?

European Journal of Cancer: Supplement · Elsevier

Аннотация

Publication date: November 2021 Source: European Journal of Cancer Supplements, Volume 16 Author(s): Martyn E. Caplin

Читать у издателя →

Похожие статьи